Group 1 - The announcement details the listing of the Fullgoal CSI Hong Kong Stock Connect High Dividend ETF on August 14, 2025, on the Shenzhen Stock Exchange [1] - The fund manager assures that the information in the listing announcement is accurate and complete, taking responsibility for any misrepresentation [1] - Investors can access the full listing announcement on the company's website and the China Securities Regulatory Commission's fund disclosure website [1] Group 2 - The Fullgoal Fund Management Company is convening a meeting for the fund holders of the Fullgoal CSI Communication Equipment Theme ETF to discuss changing the fund's custodian and amending the fund contract [3][6] - The meeting will be held via communication methods, with voting starting from August 12, 2025, to September 10, 2025 [4][6] - The rights registration date for fund holders to participate in the meeting is August 11, 2025 [6] Group 3 - The proposed agenda for the meeting includes changing the custodian of the fund to Huatai Securities Co., Ltd. and revising the fund contract [21][22] - The resolution requires approval from at least two-thirds of the voting rights represented by the fund holders [15][22] - If the proposal is approved, the fund management will modify the fund contract and disclose the updated documents accordingly [18][22]

Group 1 - The core viewpoint of the articles indicates a strong recovery in the performance of actively managed equity funds in 2025, with 95% of these funds achieving positive returns and an average return exceeding 15% as of August 7 [2][3] - The pharmaceutical sector has emerged as the biggest winner, with four actively managed equity funds achieving returns that have doubled this year, all focusing on the pharmaceutical industry [4][5] - As of mid-2025, there are 90 fund managers managing over 10 billion yuan, with Zhang Kun from E Fund leading with over 50 billion yuan under management [8][9] Group 2 - The average return of actively managed equity funds has outperformed major stock indices, such as the CSI 300 and the CSI 500, which recorded returns of 4.6% and 10.6% respectively [3] - The average return of the entire market of over 4,500 actively managed equity funds is 15.03%, compared to 11.8% for over 2,500 stock index funds [3] - Despite the overall positive performance, there are still 228 actively managed equity funds with negative returns, with the worst performer, Qianhai Kaiyuan AI A, showing a return of -18.5% [4][6] Group 3 - The top-performing funds in the pharmaceutical sector include Changcheng Pharmaceutical Industry Selection, Bank of China Hong Kong Stock Connect Pharmaceutical, Yongying Pharmaceutical Innovation Selection, and Huashan Pharmaceutical Biotechnology, all achieving significant returns [4][5] - The performance of fund managers varies significantly, with some, like Zhang Wei and Zhang Lu, achieving returns of 65.8% and 53.4% respectively, while others, such as Wang Mingxu, have negative returns [12][13] - The total scale of actively managed equity funds reached 3.39 trillion yuan by mid-2025, although the total number of shares decreased by 198.24 billion compared to the end of the previous year [6][7]

Group 1 - The core point of the announcement is the appointment of He Kang as an additional fund manager for the Zheshang Dayinjin Money Market Fund [1][4] - He Kang joined Zheshang Fund Management Co., Ltd. in July 2022 and is currently part of the fixed income department [2] - The Zheshang Dayinjin Money Market Fund A and B were established on December 1, 2016, with cumulative returns of 22.18% and 24.70% respectively as of June 16, 2025 [2] Group 2 - As of March 31, 2025, the total scale of the fund is 9.895 billion yuan [2] - The fund is managed by multiple fund managers, including He Kang, Zhao Liuyan, and Niu Guanqun [4] - The announcement is made in accordance with the "Measures for the Disclosure of Information on Publicly Raised Securities Investment Funds" [4]

Group 1 - The core viewpoint of the news is that public funds focusing on the North Exchange and innovative pharmaceuticals have shown remarkable performance in the first half of 2025, with specific funds achieving significant returns [1][2]. - The top three performing public funds as of June 30, 2025, are: 1. CITIC Construction Investment North Exchange Selected Two-Year Open Fund with a return of 82.45% 2. Great Wall Pharmaceutical Industry Selected Fund with a return of 75.18% 3. Huaxia North Exchange Innovative Small and Medium Enterprises Selected Fund with a return of 72.16% [1]. - Over the past three, five, and ten years, the top-performing funds have been: 1. Huaxia North Exchange Innovative Small and Medium Enterprises Selected Fund with a return of 175.64% 2. Jinyuan Shun'an Yuanqi Fund with a return of 297.96% 3. Huashang New Trend Preferred Fund with a return of 361.6% [1]. Group 2 - The North Exchange theme funds have performed exceptionally well, with two of the top three funds being North Exchange theme funds. CITIC Construction Investment North Exchange Selected Fund ranks first [2]. - The top holdings of CITIC Construction Investment North Exchange Selected Fund include companies listed on the North Exchange, indicating a strong focus on this market [2]. - The fund manager of CITIC Construction Investment has expressed optimism about the long-term investment potential of North Exchange companies, while also emphasizing the need to manage external uncertainties [2][3]. Group 3 - Funds focused on innovative pharmaceuticals, particularly in the innovative drug sector, have also shown strong performance, with six out of the top ten funds investing heavily in this area [4]. - The Great Wall Pharmaceutical Industry Selected Fund, managed by Liang Furui, has become the runner-up in performance, with significant holdings in companies that have seen their stock prices double this year [4]. - The fund manager believes that the innovative drug sector is at a pivotal moment, with improvements in overseas research collaborations and financial reports expected to drive future growth [4].

Group 1 - The company has decided to remove the subscription limit for institutional investors' Class A and Class C shares of the Donghai Xiangrui Bond Fund starting from August 8, 2025, allowing for normal large subscriptions [1] - The company has announced that from August 11, 2025, Guotai Haitong Securities Co., Ltd. will be added as a distribution agency for certain funds, enabling regular investment, conversion services, and participation in fee discounts [3][4] - Investors can open accounts, subscribe, redeem, and conduct other business related to the funds at Guotai Haitong Securities starting from August 11, 2025, following the relevant regulations on the agency's website [3][4] Group 2 - From August 11, 2025, investors can initiate regular investment business for the specified funds at Guotai Haitong Securities, with specific rules and procedures available on the agency's platform [4] - Fund conversion services will also be available at Guotai Haitong Securities starting from August 11, 2025, with details outlined in the latest prospectus and related announcements [6] - Investors can enjoy fee discounts when subscribing or regularly investing in the specified funds through Guotai Haitong Securities starting from August 11, 2025, with specific terms available on the agency's platform [6]

Group 1 - The core viewpoint of the articles indicates that the restoration of VAT on bond interest will create a temporary advantage for existing bonds (old bonds) over newly issued bonds (new bonds), leading to significant market fluctuations [1][2] - The yield of 10-year government bonds fell to around 1.68% before rising back above 1.7% in the afternoon, reflecting the market's reaction to the new tax policy [1] - Institutions predict that the yield spread between old and new bonds could reach 5 to 10 basis points (BP), with new bond yields likely increasing more than the decrease in old bond yields [2][3] Group 2 - Different institutions will be affected variably by the tax policy change, with banks facing the highest tax burden at 6.34% for new bonds, while asset management products will face a lower rate of 3.26% [3] - The tax burden on financial institutions may lead to a shift in investment strategies, with public funds potentially gaining a relative tax advantage, encouraging more bank funds to invest in bonds through public funds [3] - The long-term direction of the bond market will still be determined by fundamental factors, despite short-term trading opportunities created by the new tax policy [4]

Core Viewpoint - The assessment criteria for guiding funds towards sub-funds have become increasingly stringent, with new penalties for failing to meet investment return and exit plans [2][3][4]. Group 1: Fund Management Fees - Recent regulations have changed the management fee structure, limiting it to a maximum of 2% of the actual investment amount rather than the subscribed amount, which may lead to a decrease in overall management fees [4][5]. - Many GP institutions are facing deductions in management fees due to unsatisfactory performance evaluations, with some required to return previously received fees if performance metrics are not met [3][4]. - The industry is experiencing a downward trend in management fees, as new guidelines emphasize actual contributions over subscribed amounts, indicating a shift in how fees are calculated [5]. Group 2: Exit Strategies and Challenges - The current market conditions have created a backlog of projects awaiting exit, with a heavy reliance on IPOs for exits, which is becoming increasingly difficult due to a slowdown in IPO activity [6][9]. - Many GPs are struggling to meet the required DPI (Distributions to Paid-In) ratio of 1, which is critical for securing agreement from LPs for extensions on fund timelines [7][9]. - There are instances of forced exit clauses in agreements, allowing guiding funds to mandate exits under specific conditions, which adds pressure on GPs to perform [8][9]. Group 3: Relationship Between GPs and LPs - The relationship between GPs and LPs is strained, particularly with state-owned LPs who have strict requirements for performance and exit timelines, leading to potential legal actions against GPs [9][10]. - Some regions are exploring solutions to ease the pressure on GPs, such as extending the duration of fund management to accommodate current market conditions [11]. - The need for a more flexible approach in assessing GPs' performance and allowing for extensions is recognized as essential for maintaining healthy relationships in the investment ecosystem [11].

Core Insights - 华夏基金（香港） has been focusing on innovative financial products and positioning itself as a differentiated Chinese institution in the market [1][3] - The CEO, 甘添, believes that the new technology revolution is reshaping the financial industry, providing strategic opportunities for asset management institutions in Hong Kong [1][3] - The offshore RMB bond market is expected to experience explosive growth in the next three to five years, with 华夏香港 already taking the lead in this area [1][5] Company Strategy - 华夏香港 has launched several innovative products, including the first RMB-denominated public fund in Hong Kong and the largest offshore RMB money market ETF, which has grown to a scale of 4.97 billion RMB within two years [3][4] - The company has also introduced the first pure Hong Kong stock biotech ETF and the largest ESG broad-based ETF in Asia (excluding Japan), showcasing its commitment to differentiation in the ETF market [4] Market Outlook - 甘添 predicts that the offshore RMB funds pool could reach approximately 5 trillion RMB by 2030, driven by the internationalization of the RMB and the growth of the dim sum bond market [6][8] - The dim sum bond market has seen significant growth, with the market size increasing from 254 billion RMB in 2020 to nearly 1 trillion RMB currently, indicating a strong demand for these bonds [6][7] Investment Trends - The yield on dim sum bonds is currently more attractive compared to domestic bonds, leading to increased interest from domestic investors facing asset allocation challenges [7][8] - Major domestic enterprises are increasingly using dim sum bonds to replace USD-denominated bonds, reflecting a shift in financing strategies [7][8] Regulatory Environment - The Chinese government is actively supporting the internationalization of the RMB, which is expected to enhance the development of the offshore RMB market [6][8] - Recent policy optimizations, such as the cross-border wealth management connect, are facilitating domestic investors' access to offshore RMB assets, providing a stable funding source for the offshore market [8][9]

Core Insights - Wall Street Breakfast serves as a daily financial news summary, providing a quick overview of key market developments [1] Company and Industry Summary - The newsletter is designed for easy readability, catering to over 1 million subscribers, including professionals from investment banking and fund management [1] - It is published before 7:30 AM ET on every market day, ensuring timely delivery of financial news [1]

3.费率优惠活动的具体结束日期以上述销售机构公告为准，本公司不再另行公告。 4.上述适用基金的原相关费率参见基金的相关法律文件及本公司发布的最新相关公告。 一、适用基金及业务范围 ■ 注：融通内需驱动混合型证券投资基金 C类此前已公告在中国人寿上线销售，自本公告日起开通定期定 额投资业务和转换业务。 二、费率优惠内容 1.自本公告日起，投资者通过上述销售机构申购（含定期定额申购，如有）上述基金，其申购费率享有 优惠，基金具体折扣费率以上述销售机构活动公告为准。若申购费率是固定费用的，则按固定费用执 行，不再享有费率折扣。 2.申购费率优惠活动仅适用于处于正常申购期的基金产品的前端收费模式的申购手续费，不包括基金的 后端收费模式的申购手续费和处于基金募集期的基金认购费及基金其他业务的基金手续费。 为了更好地满足广大投资者的理财需求，根据融通基金管理有限公司（以下简称"融通基金"）与中国人 寿保险股份有限公司（以下简称"中国人寿"）签署的销售协议，从2025年8月1日起，融通基金旗下部分 开放式基金新增中国人寿为销售机构，并开通定期定额投资业务、转换业务，以及参加前端申购费率优 惠活动。现将有关事项公告如下： 三 ...